West Nile Encephalitis Workup

  • Author: Burke A Cunha, MD; Chief Editor: Michael Stuart Bronze, MD   more...
 
Updated: Jun 17, 2011
 

Approach Considerations

Leukopenia

West Nile encephalitis (WNE), as with many viral illnesses, may manifest as mild leukopenia or a white blood cell (WBC) count that is borderline or in the low end of the reference range. Leukocytosis suggests a complication or superinfection.

In patients who present with acute encephalitis, leukocytosis should suggest eastern equine encephalitis (EEE), California encephalitis, or St. Louis encephalitis.

Lymphopenia

Although relative lymphopenia is not specific for WNE, it is a helpful diagnostic finding if present in a patient with aseptic meningitis, meningoencephalitis, or encephalitis of unknown cause.

Although patients with human immunodeficiency virus (HIV) or Venezuelan equine encephalitis often present with encephalitis and relative lymphopenia, lymphopenia with WNE is profound and prolonged, which should suggest the diagnosis.

Serum transaminases

Mild elevations of serum glutamic-oxaloacetic transaminase (SGOT) levels are not a feature of most encephalitides due to arboviral causes.

Mild elevations of the SGOT/serum glutamic-pyruvic transaminase (SGPT) level in a patient with encephalitis should suggest Epstein-Barr virus, Rocky Mountain spotted fever, ehrlichiosis, human herpesvirus type 6 infection, or Legionnaires disease, in addition to WNE. Serum amylase/lipase levels are increased in some cases of WNE.

Serum ferritin levels

Serum ferritin levels are highly elevated in WNE and not in other causes of encephalitis. The magnitude/duration of serum ferritin elevations also host prognostic importance.

Electroencephalography

This is the most sensitive method of making a presumptive diagnosis of HSV-1 encephalitis. Electroencephalography reveals an abnormal temporal lobe focus as early as the first few days of the disease.

The electroencephalogram in patients with WNE shows diffuse bilateral focal abnormalities in the temporal lobe.[10]

Lumbar puncture

CSF reveals mild to moderate pleocytosis with a lymphocytic predominance in WNE.[11, 12] CSF protein levels are variably elevated, and the CSF glucose level is not decreased.

The CSF lactic acid level is not elevated, and RBCs, excluding traumatic taps, are not present in WNE. CSF Gram stain and bacterial culture findings are negative.

Histologic findings

Brain biopsy findings exhibit diffuse encephalitis, which is nonspecific and nondiagnostic for WNE.

Next

Serologic Testing

West Nile encephalopathy (WNE) may be cultured from the blood within the first 2 weeks of initial infection, but it is not usually culturable from CSF.

A specific diagnosis can be confirmed via serum testing. Various serologic methods are available, but the enzyme immunoassay (EIA) with plaque reduction neutralization test is the best test currently available. The polymerase chain reaction assay is also available at selected research centers. A highly elevated acute titer or a 4-fold or greater rise between acute and convalescent titer is diagnostic of WNE.

Previous
Next

CT Scanning and MRI

Since the differential diagnoses of WNE include HSV-1 meningoencephalitis and encephalitis, a head CT or MRI scan is helpful in excluding HSV-1 infection, the only treatable cause of viral encephalitis.

CT or MRI scans may exhibit changes in 1 temporal lobe, which is highly characteristic of HSV-1 encephalitis. Early CT scan and MRI findings are often negative. CT scans are less sensitive and may not reveal abnormalities if obtained very early in the disease process.

All other causes of aseptic meningitis, meningoencephalitis, or encephalitis, including systemic disorders with an encephalitic component, yield negative findings (nonfocal temporal lobe findings) on CT and MRI scans.

CNS lupus may be suggested by the diffuse uptake over the cerebral cortex, suggesting cerebritis.

Previous
 
 
Contributor Information and Disclosures
Author

Burke A Cunha, MD  Professor of Medicine, State University of New York School of Medicine at Stony Brook; Chief, Infectious Disease Division, Winthrop-University Hospital

Burke A Cunha, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Specialty Editor Board

Wesley W Emmons, MD, FACP  Assistant Professor, Department of Medicine, Thomas Jefferson University; Consulting Staff, Infectious Diseases Section, Department of Internal Medicine, Christiana Care, Newark, DE

Wesley W Emmons, MD, FACP is a member of the following medical societies: American College of Physicians, American Medical Association, American Society of Tropical Medicine and Hygiene, Infectious Diseases Society of America, and International AIDS Society

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

John L Brusch, MD, FACP  Assistant Professor of Medicine, Harvard Medical School; Consulting Staff, Department of Medicine and Infectious Disease Service, Cambridge Health Alliance

John L Brusch, MD, FACP is a member of the following medical societies: American College of Physicians and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Chief Editor

Michael Stuart Bronze, MD  Professor, Stewart G Wolf Chair in Internal Medicine, Department of Medicine, University of Oklahoma Health Science Center

Michael Stuart Bronze, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Physician Executives, American College of Physicians, American College of Physicians-American Society of Internal Medicine, American Federation for Clinical Research, American Medical Association, American Society for Microbiology, Association of Professors of Medicine, Association of Program Directors in Internal Medicine, Infectious Diseases Society of America, Oklahoma State Medical Association, and Southern Society for Clinical Investigation

Disclosure: Nothing to disclose.

References
  1. Cunha BA. Alexander the Great and West Nile virus encephalitis. Emerg Infect Dis. Jul 2004;10(7):1328-9; author reply 1332-3. [Medline].

  2. Oldach D, Benitez RM, Mackowiak PA. Alexander the Great and West Nile virus encephalitis. Emerg Infect Dis. Jul 2004;10(7):1329-30; author reply 1332-3. [Medline].

  3. MacDonald RD, Krym VF. West Nile virus. Primer for family physicians. Can Fam Physician. Jun 2005;51:833-7. [Medline]. [Full Text].

  4. Petersen LR, Marfin AA. West Nile virus: a primer for the clinician. Ann Intern Med. Aug 6 2002;137(3):173-9. [Medline].

  5. Murray K, Baraniuk S, Resnick M, Arafat R, Kilborn C, Cain K, et al. Risk factors for encephalitis and death from West Nile virus infection. Epidemiol Infect. Dec 2006;134(6):1325-32. [Medline]. [Full Text].

  6. Wadei H, Alangaden GJ, Sillix DH, et al. West Nile virus encephalitis: an emerging disease in renal transplant recipients. Clin Transplant. Dec 2004;18(6):753-8. [Medline].

  7. Zou S, Foster GA, Dodd RY, Petersen LR, Stramer SL. West Nile fever characteristics among viremic persons identified through blood donor screening. J Infect Dis. Nov 1 2010;202(9):1354-61. [Medline].

  8. Abroug F, Ouanes-Besbes L, Letaief M, et al. A cluster study of predictors of severe West Nile virus infection. Mayo Clin Proc. Jan 2006;81(1):12-6. [Medline]. [Full Text].

  9. Nash D, Mostashari F, Fine A, et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med. Jun 14 2001;344(24):1807-14. [Medline].

  10. Rodriguez AJ, Westmoreland BF. Electroencephalographic characteristics of patients infected with west nile virus. J Clin Neurophysiol. Oct 2007;24(5):386-9. [Medline].

  11. Rawal A, Gavin PJ, Sturgis CD. Cerebrospinal fluid cytology in seasonal epidemic West Nile virus meningo-encephalitis. Diagn Cytopathol. Feb 2006;34(2):127-9. [Medline].

  12. Tyler KL, Pape J, Goody RJ, et al. CSF findings in 250 patients with serologically confirmed West Nile virus meningitis and encephalitis. Neurology. Feb 14 2006;66(3):361-5. [Medline].

  13. Murray KO, Resnick M, Miller V. Depression after infection with West Nile virus. Emerg Infect Dis. Mar 2007;13(3):479-81. [Medline]. [Full Text].

  14. Ou AC, Ratard RC. One-year sequelae in patients with West Nile Virus encephalitis and meningitis in Louisiana. J La State Med Soc. Jan-Feb 2005;157(1):42-6. [Medline].

  15. Sejvar JJ. The long-term outcomes of human West Nile virus infection. Clin Infect Dis. Jun 15 2007;44(12):1617-24. [Medline].

  16. Cunha BA. Differential diagnosis of West Nile encephalitis. Curr Opin Infect Dis. Oct 2004;17(5):413-20. [Medline].

  17. Cunha BA, Minnaganti V, Johnson DH, Klein NC. Profound and prolonged lymphocytopenia with West Nile encephalitis. Clin Infect Dis. Oct 2000;31(4):1116-7. [Medline].

  18. Cunha BA, Sachdev B, Canario D. Serum ferritin levels in West Nile encephalitis. Clin Microbiol Infect. Feb 2004;10(2):184-6. [Medline].

Previous
Next
 
Common encephalitis associations.
Clinical features of arboviral encephalitis.
Differential diagnoses of meningoencephalitis.
The Culex mosquito, common in the eastern United States, is the primary vector responsible for infecting humans with West Nile virus. Prevention of West Nile virus is primarily directed at reducing the mosquito population from May to October and by taking precautions to limit human exposure during these months of high mosquito activity. Image courtesy of the Centers for Disease Control and Prevention.
The geographic distribution of the Japanese encephalitis servocomplex of the family Flaviridae, 2000. Image courtesy of the Centers for Disease Control and Prevention.
States reporting laboratory-positive West Nile virus infection in birds, mosquitoes, animals, or humans between January 1 and August 28, 2002. Image courtesy of the Centers for Disease Control and Prevention.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.